The Parkinson s Progression Markers Initiative (PPMI) 2.0 Clinical - Establishing a Deeply Phenotyped PD Cohort

Go Back to All Clinical Trials

The Parkinson s Progression Markers Initiative (PPMI) 2.0 Clinical - Establishing a Deeply Phenotyped PD Cohort

Brief description of study

The purpose of this study is to continue to obtain information from people with and without Parkinson disease (PD) so that researchers may better understand how Parkinson disease progresses, in order to inform better treatments. The information collected in this study is for research and not for clinical care. This study is an expansion of the PPMI study that has been ongoing for nearly ten years. The information this study will collect clinical information, brain imaging scans, samples of blood, urine, cerebral spinal fluid, information from digital applications and self-reported information from questionnaires completed online. Participants may be asked if they are interested in enrolling in a brain and tissue bank.

Clinical Study Identifier: s20-01215

Principal Investigator: Giulietta Maria Riboldi.

Other Investigators: Un Kang, Andrew S. Feigin.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies